|
Re: Exempt Distribution Jan 20
|
3
|
Zenith Epigenetics
|
Jan 30, 2021 09:09AM
|
|
Monday
|
3
|
Resverlogix Corp.
|
Oct 01, 2020 05:26PM
|
|
Re: Exempt Distribution Jan 20
|
3
|
Zenith Epigenetics
|
Jan 30, 2021 09:11AM
|
|
Re: 2 new upcoming presentations
|
3
|
Resverlogix Corp.
|
May 02, 2020 06:41PM
|
|
Early
|
3
|
Resverlogix Corp.
|
Jan 07, 2021 04:00PM
|
|
2020
|
3
|
Resverlogix Corp.
|
Jan 01, 2020 10:36AM
|
|
Re: 2 new upcoming presentations
|
3
|
Resverlogix Corp.
|
May 03, 2020 09:02AM
|
|
Re: everything r v x is down 4% to around 24%
|
3
|
Resverlogix Corp.
|
Jan 27, 2021 04:54PM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 01:54PM
|
|
Vancouver Zen
|
3
|
Zenith Epigenetics
|
Dec 13, 2020 10:38AM
|
|
Re: Communications
|
3
|
Resverlogix Corp.
|
Feb 04, 2020 03:54PM
|
|
Two hours
|
3
|
Resverlogix Corp.
|
Jan 10, 2020 01:48PM
|
|
Re: Thanks GAC!.....
|
3
|
Resverlogix Corp.
|
Jan 16, 2020 12:29PM
|
|
Re: Message from Sarah this early afternoon regarding the warrants
|
3
|
Resverlogix Corp.
|
Jan 10, 2020 02:05PM
|
|
Deloitte
|
3
|
Resverlogix Corp.
|
May 06, 2021 09:27AM
|
|
Exempt
|
3
|
Resverlogix Corp.
|
Mar 24, 2021 02:58PM
|
|
Chinese
|
3
|
Resverlogix Corp.
|
Jul 13, 2020 01:52PM
|
|
Re: Pfizer's plans for research: sounds like RVX!
|
3
|
Resverlogix Corp.
|
Jan 29, 2020 01:37PM
|
|
Finance
|
2
|
Resverlogix Corp.
|
Feb 06, 2021 09:05AM
|
|
Re: Name Confusion
|
2
|
Zenith Epigenetics
|
Jul 25, 2020 04:39PM
|
